Rehabilitation in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD)

Overview

The study is a single-center randomized, unblinded, placebo-controlled study to investigate the effect of pulmonary rehabilitation in subjects with moderate chronic obstructive pulmonary disease (COPD).

Full Title of Study: “Early Detection and Rehabilitation of Subjects With COPD – Rehabilitation in Moderate COPD”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 2011

Interventions

  • Behavioral: Pulmonary rehabilitation
  • Behavioral: conventional care

Arms, Groups and Cohorts

  • Active Comparator: Pulmonary rehabilitation
    • A standardized 7 week rehabilitation program, including physical training and education.
  • Placebo Comparator: Control
    • Conventional care

Participating in This Clinical Trial

Inclusion Criteria

1. A diagnosis of moderate COPD. 2. Motivation for Pulmonary rehabilitation. Exclusion Criteria:

1. Comorbidity contraindicating rehabilitation. 2. Participation in pulmonary rehabilitation within the last year. 3. Cognitive disorders limiting the ability to participate in physical training and education sessions.

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Bispebjerg Hospital
  • Collaborator
    • Ministry of the Interior and Health, Denmark
  • Provider of Information About this Clinical Study
    • Vibeke Backer, professor, MD., The Department of Respiratory Medicine, L, Bispebjerg Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.